This was a round table discussion about what it takes to get a...

This was a round table discussion about what it takes to get a drug approved, not what it takes to make money investing in biotech. It takes many years to get a drug approved even with accelerated approval. This is not the same as getting a good return from investing in a biotech as you don’t need a company to have an approved drug to get a good return.

To give you a relevant example based on today’s news, I invested a large chunk of money in DXB last June when the share price was 5c. Today the SP is 42.5c and DXB still don’t have an approved drug, nor will they for a number of years. Investing in listed biotechs is a long journey, but you can get on and off whenever you want.